https://doi.org/10.4081/aiua.2025.13492
Supratrigonal systectomy: last line treatment for radiation-induced hemorrhagic cystitis
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 26 May 2025
Introduction: Hemorrhagic cystitis is defined by the presence of hematuria, lower urinary tract symptoms and cystoscopy findings indicative of underlying urothelial damage. It is common in patients with prior radiotherapy for pelvic malignancies. The severity of the bleeding can vary from mild to severe hematuria refractory to conservative therapy and with a continuous need for transfusions. Treatment can be challenging not only by the lack of clear guidelines but also the multiple comorbidities of these patients. Urinary diversion with or without cystectomy should be reserved for those who have failed all the previously available therapy, because of the morbidity/mortality associated with this type of procedure. Supratrigonal cystectomy can be an option in patients with intense fibrosis of the pelvic region. The purpose of this article is to present the results of our institution with supratrigonal cystectomy with urinary diversion as a last line treatment for radiation-induced hemorrhagic cystitis.
Materials and methods: We retrospectively analyzed 17 patients who underwent supratrigonal cystectomy and bladder mucosa fulguration with urinary diversion for refractory radiation-induced hemorrhagic cystitis in our institution from January 2010 to December 2020.
Results and discussion: Median patient age at time of cystectomy was 69 years and 64.7% (11) were females. The most common etiology was prior radiation therapy for gynecologic malignancies (11-64.7%). All the patients had prior therapy with bladder irrigation and fulguration. Besides that, 29.4% (n=5) received intravesical therapy with formalin, 11.8% (n=2) hyperbaric oxygen therapy and 5.9% (n=1) prior urinary diversion. Median time between radiation therapy and cystectomy was 65 months. Median ASA score of 3, median preoperative hemoglobin was 9,6mg/dl and 10.5 mg/dl at time of discharge after surgery. Ileal conduit was used in 52.9% (9), cutaneous ureterostomy in 41.2% (7) and ureterosigmoidostomy in 5.9% (1). Majority of patients (10-58.8%) did not require any blood transfusion during surgery or during their stay. Clavien-Dindo complications grade III or higher occurred in 29,4% (5). Median hospital stay postoperative was 12 days. No mortality was reported in the 30 days after surgery. Median follow-up after cystectomy was 28 months, with a 1-year survival of 93.3% (14 of 15) and 3-year survival of 83.3% (10 of 13). There was no difference in the presence of postoperative complications or overall survival between the types of urinary diversion.
Conclusions: This represents one of the largest series on cystectomy in hemorrhagic cystitis, that we found to this date. Supratrigonal cystectomy is a valid option as a last line treatment for radiation-induced hemorrhagic cystitis, reducing the risks associated with simple cystectomy in patients with prior pelvic radiation.
Downloads
Smit SG, Heyns CF. Management of radiation cystitis. Nat Rev Urol. 2010; 7:1-15. DOI: https://doi.org/10.1038/nrurol.2010.23
Crew JP, Jephcott CR, Reynard JM. Radiation-induced haemorrhagic cystitis. Eur Urol. 2001;40:111-23. DOI: https://doi.org/10.1159/000049760
Goucher G, Saad F, Lukka H, Kapoor A. Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagic cystitis. Can Urol Assoc J. 2019;13:15-23. DOI: https://doi.org/10.5489/cuaj.5788
Martin SE, Begun EM, Samir E, et al. Incidence and morbidity of radiation-induced hemorrhagic cystitis in prostate cancer. Urology. 2019; 131:190-5. DOI: https://doi.org/10.1016/j.urology.2019.05.034
Ju Z, Yu W, Li Y, et al. The clinical research of 5 steps sequential method for whole treatment of hemorrhagic radiation cystitis in china. Int J Med Sci. 2021; 18:756-62. DOI: https://doi.org/10.7150/ijms.47906
Eisenberg MS, Dorin RP, Bartsch G, et al. Early complications of cystectomy after high dose pelvic radiation. JURO 2010;184:2264-9. DOI: https://doi.org/10.1016/j.juro.2010.08.007
Rowley MW, Clemens JQ, Latini JM, Cameron AP. Simple cystectomy: outcomes of a new operative technique. J Urol. 2011;78:942-5. DOI: https://doi.org/10.1016/j.urology.2011.05.046
Linder BJ, Tarrell RF, Boorjian SA. Cystectomy for refractory hemorrhagic cystitis: Contemporary etiology, presentation and outcomes. J Urol. 2014; 192:1687-92. DOI: https://doi.org/10.1016/j.juro.2014.06.030
Tachibana I, Calaway AC, Abedali Z, et al. Definitive surgical therapy for refractory radiation cystitis: Evaluating effectiveness, tolerability, and extent of surgical approach. Urol Oncol. 2021;39:789.e1-789.e7.
Dindo D, Demartines N, Clavien P. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240:205-13. DOI: https://doi.org/10.1097/01.sla.0000133083.54934.ae
Moschini M, Zaffuto E, Karakiewicz PI, et al. external beam radiotherapy increases the risk of bladder cancer when compared with radical prostatectomy in patients affected by prostate cancer: a population-based analysis. Eur Urol. 2019; 75:319-28. DOI: https://doi.org/10.1016/j.eururo.2018.09.034
Pereira D, Ferreira C, Catarino R, et al. Oxígeno hiperbárico para la cistitis inducida por radioterapia: un seguimiento a largo plazo. Actas Urol Es. 2020; 44:561-7. DOI: https://doi.org/10.1016/j.acuro.2020.03.010
Ribeiro de Oliveira TM, Carmelo Romão AJ, Simões de Oliveira PM, et al. Oxigenoterapia hiperbárica na cistite rádica hemorrágica. Acta Urológica Port. 2016; 33:1-5. DOI: https://doi.org/10.1016/j.acup.2016.02.001
Oscarsson N, Müller B, Rosén A, et al. Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial. Lancet Oncol. 2019;20:1602-14. DOI: https://doi.org/10.1016/S1470-2045(19)30494-2
Korkmaz M, Åžanal B, Aras B, et al. The short-and long-term effectiveness of transcatheter arterial embolization in patients with intractable hematuria. Diagn Interv Imaging. 2016;97:197-201. DOI: https://doi.org/10.1016/j.diii.2015.06.020
Mohan S, Kumar S, Dubey D, et al. Superselective vesical artery embolization in the management of intractable hematuria secondaryto hemorrhagic cystitis. World J Urol. 2019;37:2175-82. DOI: https://doi.org/10.1007/s00345-018-2604-0
Fazili T, Bhat TR, Masood S, et al. Fate of the leftover bladder after supravesical urinary diversion for benign disease. J Urol. 2006; 176:620-1. DOI: https://doi.org/10.1016/j.juro.2006.03.056
Chong JT, Dolat MT, Klausner AP, et al. The role of cystectomy for non-malignant bladder conditions: a review. Can J Urol. 2014;21:7433-41.
Vetterlein MW, Buhné MJ, Yu H, et al. Urinary diversion with or without concomitant cystectomy for benign conditions: a comparative morbidity assessment according to the updated European Association of Urology guidelines on reporting and grading of complications. Eur Urol Focus. 2022; 8:1831-9. DOI: https://doi.org/10.1016/j.euf.2022.02.008
Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009; 55:164-76. DOI: https://doi.org/10.1016/j.eururo.2008.07.031
Pascoe C, Duncan C, Lamb BW, et al. Current management of radiation cystitis: A review and practical guide to clinical management. BJU Int. 2019; 123:585-94. DOI: https://doi.org/10.1111/bju.14516
Kim HL, Steinberg GD. Complications of cystectomy in patients with a history of pelvic radiation. Urology 2001;58:557-60. DOI: https://doi.org/10.1016/S0090-4295(01)01269-9
Korkes F, Fernandes E, Gushiken FA, et al. Bricker ileal conduit vs. Cutaneous ureterostomy after radical cystectomy for bladder cancer: a systematic review. Int Braz J Urol. 2022; 48:18-30. DOI: https://doi.org/10.1590/s1677-5538.ibju.2020.0892
Suzuki K, Hinata N, Inoue TA, et al. Comparison of the perioperative and postoperative outcomes of ileal conduit and cutaneous ureterostomy: a propensity score-matched analysis. Urol Int. 2020; 104:48-54. DOI: https://doi.org/10.1159/000504681
Linn JF, Hohenfellner M, Roth S, et al. Treatment of interstitial cystitis: comparison of subtrigonal and supratrigonal cystectomy combined with orthotopic bladder substitution. J Urol. 1998;159:774-8. DOI: https://doi.org/10.1016/S0022-5347(01)63726-1
Osborn DJ, Dmochowski RR, Kaufman MR, et al. Cystectomy with urinary diversion for benign disease: indications and outcomes. Urology 2014; 51590:1-5. DOI: https://doi.org/10.1016/j.urology.2014.02.030
Tachibana I, Calaway AC, Abedali Z, et al. Definitive surgical therapy for refractory radiation cystitis: Evaluating effectiveness, tolerability, and extent of surgical approach. Urol Oncol Semin Orig Investig. 2021; 39:1-7. DOI: https://doi.org/10.1016/j.urolonc.2021.05.038
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.